Content about Sandoz

May 22, 2013
FDA approves Sandoz hypertension drug

The Food and Drug Administration has approved a generic heart disease drug made by Sandoz, the company said.

April 23, 2013
Sandoz VP leaves company

Sandoz U.S. Generics Operating Unit VP sales and marketing Rich Tremonte will leave the company.

April 22, 2013
NACDS Foundation announces five new board members

The National Association of Chain Drug Stores Foundation announced the election of five new members to its board of directors.

April 17, 2013
Sandoz launches generic cardiovascular disease drug

Generic drug maker Sandoz has launched a generic version of a drug used to treat high blood pressure and angina.

March 20, 2013
Sandoz launches generic contraceptives

The Food and Drug Administration has approved and launched two generic contraceptives made by Sandoz, the drug maker said.

February 6, 2013
FDA approves Sandoz antibiotic

The Food and Drug Administration has approved a generic antibiotic made by Sandoz, the drug maker said Wednesday.

November 15, 2012
Generic drugs compete in game of differentiation

The year 2012 is coming to an end, and it’s been a big year for 
generic drugs.


November 5, 2012
Watson-Actavis latest among generic M&As

In what its president and CEO called a “significant milestone,” Watson Pharmaceuticals announced last month that the U.S. Federal Trade Commission and European Commission had approved its acquisition of Swiss generic drug maker Actavis.

October 31, 2012
Sandoz starts phase-3 trial of biosimilar anemia drug

Generic drug maker Sandoz has started a late-stage clinical trial in the United States for a biosimilar treatment for anemia, the company said.

October 23, 2012
United Therapeutics awaits FDA decision on oral PAH drug as Sandoz seeks generic approval

The Food and Drug Administration is expected to decide at the end of this week whether to approve a new oral drug for pulmonary arterial hypertension made by United Therapeutics.

October 16, 2012
FTC approves Watson-Actavis merger

The Federal Trade Commission has voted to approve Watson Pharmaceutical's acquisition of Switzerland-based generic drug maker Actavis.

October 12, 2012
FDA approves Sandoz dermatology drug

The Food and Drug Administration has approved a drug made by Sandoz for treating symptoms of various skin diseases.

September 24, 2012
Sandoz launches authorized generic of Diovan HCT

Generic drug maker Sandoz has launched an authorized generic version of a drug used to treat hypertension.

August 6, 2012
Sandoz launches generic psoriasis treatment

Sandoz has launched a generic version of a topical medication used to treat psoriasis, the company said.

June 6, 2012
Dr. Reddy's, Merck KGaA partner on biosimilars

A generic drug maker in India and a German pharmaceutical company will collaborate to develop biosimilars.

May 11, 2012
Amgen offers testimony at FDA biosimilars hearing

Biotech drug maker Amgen has joined the list of companies offering testimony at a Food and Drug Administration hearing on biosimilars Friday.

May 9, 2012
Sandoz to testify at FDA biosimilars hearing

The Food and Drug Administration should apply consistent regulatory standards across all biologics, Sandoz plans to state Friday in testimony at an FDA public hearing on draft guidances related to the development of biosimilars.

May 2, 2012
Sandoz acquires Fougera for $1.5 billion

Novartis' generics division has acquired Fougera Pharmaceuticals, the company said Wednesday.

February 23, 2012
Mylan's Tony Mauro elected as GPhA chairman

The president of one of the world's largest generic drug manufacturers will serve as chairman of the Generic Pharmaceutical Association, the organization said Thursday.

January 26, 2012
Federal court clears way for Watson, Amphastar to launch generic version of Lovenox

A federal court has stopped an injunction that would have prevented drug maker Watson Pharmaceuticals and partner company Amphastar Pharmaceuticals from marketing or selling a generic version of a blood-thinning drug.

January 20, 2012
Generics cos. turn to biosimilars as patent cliff approaches

With the patent cliff and subsequent innovation drought moving closer, generic drug makers are looking to move up the value chain and pursue new sources of revenue, and of all the piles of pay dirt out there, biosimilars represent one of the closest things to an El Dorado, though regulations won’t take their final form for a while.


January 19, 2012
Sandoz starts two late-stage biosimilar trials

Drug maker Sandoz has started two late-stage clinical trials of biosimilar drugs for treating cancer patients undergoing chemotherapy, the company said Thursday, saying the studies were meant to support the drugs' eventual marketing in the United States.

January 6, 2012
Sandoz launches authorized generic shampoo for severe scalp psoriasis

Sandoz has launched a shampoo used to treat severe scalp psoriasis, the generic drug maker said.

December 19, 2011
FDA approves Sandoz drug for fungal infections

The Food and Drug Administration has approved a drug made by Sandoz for treating yeast and other fungal infections.

October 27, 2011
Innopharma receives FDA approval for generic Zyprexa injection

A company focused on developing niche generic and specialty pharmaceutical products has received regulatory approval from the Food and Drug Administration for its version of a psychiatric drug.

© 2013 Drug Store News. All Rights Reserved.